AMFR and cancer: The anti-Gp78 monoclonal antibody, 3F3A, has extensively been utilized to study Gp78/AMFR in cancer, and more recently has been shown to selectively recognize a non-phosphorylated (on Serine 538) form of Gp78 [6, 7].